Weekly Progress Report: This Model Portfolio Company Is Betting Big on New Jersey
Rubicon Organics Achieves Major Milestones for Growth
Our 5-Rated Portfolio Member Joins the Russell 3000
Weekly Progress Report: Expect More Sales Than Ever for This CBD Drug Maker
This Cannabis-Focused Biotech Company Could Be Onto Something Big
A Rare Opportunity to Invest in a Startup With a Proven Record of Success
Weekly Progress Report: Expansions, Purchases, and Dividend Hikes for Our Newest Model Portfolio Companies
Expansion in NJ, CT, and Bigger Dividend Payouts Lead the News for Your Model Portfolio This Week
At the End of the Day, Federal Legalization Comes Down to This
Weekly Progress Report: Uncovering CBD’s True Potential as a COVID-19 Therapy
